# Denileukine Diftitox for Relapsed ALCL

> **NCT00801918** · PHASE2 · WITHDRAWN · sponsor: **Columbia University**

## Conditions studied

- Anaplastic Large-Cell Lymphoma

## Interventions

- **DRUG:** Denileukin Diftitox
- **DRUG:** Denileukin diftitox, ifosfamide, cyclophosphamide, etoposide

## Key facts

- **NCT ID:** NCT00801918
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-12
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2013-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801918, "Denileukine Diftitox for Relapsed ALCL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00801918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*